JP Stock MarketDetailed Quotes

4884 Kringle Pharma

Watchlist

896
+45+5.29%

20min DelayMarket Closed Mar 28 15:30 JST

6.13BMarket Cap-7.58P/E (Static)

Kringle Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Sep 30, 2024

(FY)Sep 30, 2023

(FY)Sep 30, 2022

(FY)Sep 30, 2021

(FY)Sep 30, 2020

(FY)Sep 30, 2019

(FY)Sep 30, 2018

Operating cash flow (Indirect Method)

Cash from operating activities

2.45%-816.98M

-157.83%-837.53M

49.75%-324.84M

-165.98%-646.43M

36.02%-243.04M

-40.69%-379.86M

-269.99M

Net profit before non-cash adjustment

11.46%-754.96M

-158.12%-852.66M

-10.23%-330.34M

-157.58%-299.68M

61.43%-116.34M

-370.31%-301.63M

---64.13M

Total adjustment of non-cash items

-88.73%-41.6M

67.35%-22.04M

39.36%-67.52M

-147.56%-111.34M

30.33%-44.97M

60.49%-64.55M

---163.39M

-Other non-cash items

-88.73%-41.6M

67.35%-22.04M

39.36%-67.52M

-147.56%-111.34M

30.33%-44.97M

60.49%-64.55M

---163.39M

Changes in working capital

-154.92%-20.42M

-49.09%37.17M

131.01%73.01M

-188.05%-235.42M

-497.78%-81.73M

67.80%-13.67M

---42.47M

-Change in receivables

309.57%24.6M

-188.33%-11.74M

-86.59%13.29M

194.90%99.11M

-532.13%-104.44M

-288.34%-16.52M

--8.77M

-Change in inventory

590.42%69.54M

59.23%-14.18M

87.06%-34.78M

-887.86%-268.73M

-41.96%-27.2M

---19.16M

----

-Change in prepaid assets

-1,244.00%-55.66M

-106.91%-4.14M

317.15%59.9M

-18.12%-27.58M

-294.77%-23.35M

125.78%11.99M

---46.51M

-Change in payables

-195.75%-123.65M

489.80%129.14M

152.64%21.9M

-251.62%-41.59M

173.70%27.43M

311.86%10.02M

---4.73M

-Changes in other current assets

204.59%64.75M

-587.07%-61.91M

276.96%12.71M

-92.64%3.37M

--45.83M

----

Dividends paid (cash flow from operating activities)

Dividends received (cash flow from operating activities)

Interest paid (cash flow from operating activities)

Interest received (cash flow from operating activities)

100.00%10K

81K

Tax refund paid

-0.07%-1.49M

-123.79%-1.49M

520.40%6.26M

-254.76%-1.49M

0.00%-420K

-420K

Other operating cash inflow (outflow)

4.92%157.29M

-55.16%149.92M

284.34%334.38M

-10.31%87M

133.88%97M

-38.93%41.47M

67.91M

Operating cash flow

4.05%-661.17M

-4,462.47%-689.1M

102.82%15.8M

-282.98%-560.92M

56.77%-146.46M

-67.38%-338.8M

---202.42M

Investing cash flow

Net investment product transactions

-0.34%-121.28M

52.48%-120.88M

---254.37M

----

Net changes in other investments

---82K

----

---9K

----

--1K

Investing cash flow

-0.40%-121.36M

52.48%-120.88M

---254.38M

----

--1K

Financing cash flow

Net common stock issuance

1,134.11%838.23M

-88.72%67.92M

-1.66%602.04M

-70.60%612.19M

--2.08B

----

--199.27M

Net other fund-raising expenses

-100.08%-1K

16.18%1.24M

106.57%1.07M

---16.28M

----

Financing cash flow

1,111.95%838.23M

-88.53%69.16M

1.21%603.11M

-71.39%595.9M

--2.08B

----

--199.27M

Net cash flow

Beginning cash position

-29.61%1.76B

17.05%2.5B

1.66%2.14B

1,162.97%2.1B

-67.05%166.48M

-0.62%505.28M

--508.42M

Current changes in cash

107.52%55.7M

-303.23%-740.81M

942.04%364.53M

-98.19%34.98M

671.45%1.94B

-10,686.41%-338.8M

---3.14M

Cash adjustments other than cash changes

----

-200.00%-1K

--1K

----

-200.00%-1K

--1K

End cash Position

3.16%1.82B

-29.61%1.76B

17.05%2.5B

1.66%2.14B

1,162.97%2.1B

-67.05%166.48M

--505.28M

Free cash flow

4.05%-661.17M

-4,462.47%-689.1M

102.82%15.8M

-282.98%-560.92M

56.77%-146.46M

-67.38%-338.8M

---202.42M

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Sep 30, 2024	(FY)Sep 30, 2023	(FY)Sep 30, 2022	(FY)Sep 30, 2021	(FY)Sep 30, 2020	(FY)Sep 30, 2019	(FY)Sep 30, 2018
Operating cash flow (Indirect Method)
Cash from operating activities	2.45%-816.98M	-157.83%-837.53M	49.75%-324.84M	-165.98%-646.43M	36.02%-243.04M	-40.69%-379.86M	-269.99M
Net profit before non-cash adjustment	11.46%-754.96M	-158.12%-852.66M	-10.23%-330.34M	-157.58%-299.68M	61.43%-116.34M	-370.31%-301.63M	---64.13M
Total adjustment of non-cash items	-88.73%-41.6M	67.35%-22.04M	39.36%-67.52M	-147.56%-111.34M	30.33%-44.97M	60.49%-64.55M	---163.39M
-Other non-cash items	-88.73%-41.6M	67.35%-22.04M	39.36%-67.52M	-147.56%-111.34M	30.33%-44.97M	60.49%-64.55M	---163.39M
Changes in working capital	-154.92%-20.42M	-49.09%37.17M	131.01%73.01M	-188.05%-235.42M	-497.78%-81.73M	67.80%-13.67M	---42.47M
-Change in receivables	309.57%24.6M	-188.33%-11.74M	-86.59%13.29M	194.90%99.11M	-532.13%-104.44M	-288.34%-16.52M	--8.77M
-Change in inventory	590.42%69.54M	59.23%-14.18M	87.06%-34.78M	-887.86%-268.73M	-41.96%-27.2M	---19.16M	----
-Change in prepaid assets	-1,244.00%-55.66M	-106.91%-4.14M	317.15%59.9M	-18.12%-27.58M	-294.77%-23.35M	125.78%11.99M	---46.51M
-Change in payables	-195.75%-123.65M	489.80%129.14M	152.64%21.9M	-251.62%-41.59M	173.70%27.43M	311.86%10.02M	---4.73M
-Changes in other current assets	204.59%64.75M	-587.07%-61.91M	276.96%12.71M	-92.64%3.37M	--45.83M	----	----
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
Interest received (cash flow from operating activities)	100.00%10K	5K	0	1K	0	0	81K
Tax refund paid	-0.07%-1.49M	-123.79%-1.49M	520.40%6.26M	-254.76%-1.49M	0.00%-420K	0.00%-420K	-420K
Other operating cash inflow (outflow)	4.92%157.29M	-55.16%149.92M	284.34%334.38M	-10.31%87M	133.88%97M	-38.93%41.47M	67.91M
Operating cash flow	4.05%-661.17M	-4,462.47%-689.1M	102.82%15.8M	-282.98%-560.92M	56.77%-146.46M	-67.38%-338.8M	---202.42M
Investing cash flow
Net investment product transactions	-0.34%-121.28M	52.48%-120.88M	---254.37M	----	----	----	----
Net changes in other investments	---82K	----	---9K	----	----	----	--1K
Investing cash flow	-0.40%-121.36M	52.48%-120.88M	---254.38M	----	----	----	--1K
Financing cash flow
Net common stock issuance	1,134.11%838.23M	-88.72%67.92M	-1.66%602.04M	-70.60%612.19M	--2.08B	----	--199.27M
Net other fund-raising expenses	-100.08%-1K	16.18%1.24M	106.57%1.07M	---16.28M	----	----	----
Financing cash flow	1,111.95%838.23M	-88.53%69.16M	1.21%603.11M	-71.39%595.9M	--2.08B	----	--199.27M
Net cash flow
Beginning cash position	-29.61%1.76B	17.05%2.5B	1.66%2.14B	1,162.97%2.1B	-67.05%166.48M	-0.62%505.28M	--508.42M
Current changes in cash	107.52%55.7M	-303.23%-740.81M	942.04%364.53M	-98.19%34.98M	671.45%1.94B	-10,686.41%-338.8M	---3.14M
Cash adjustments other than cash changes	----	-200.00%-1K	--1K	----	----	-200.00%-1K	--1K
End cash Position	3.16%1.82B	-29.61%1.76B	17.05%2.5B	1.66%2.14B	1,162.97%2.1B	-67.05%166.48M	--505.28M
Free cash flow	4.05%-661.17M	-4,462.47%-689.1M	102.82%15.8M	-282.98%-560.92M	56.77%-146.46M	-67.38%-338.8M	---202.42M
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

4884 Kringle Pharma

Kringle Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Market Insights